| Multiple Sclerosis References |
|
[1] Beers M and Berkow R. The Merck Manual; 17th Ed. 1999. Multiple sclerosis; pp: 1474-1476.
[2] Pizzorno J, Murray M, and Joiner-Bey H. The Clinician's Handbook of Natural Medicine. 2002 Churchill Livingstone, New York; pp: 344-351.
[4]
Pizzorno J, Murray M, and Joiner-Bey
H. The Clinician's Handbook of
Natural Medicine. 2002 Churchill
Livingstone, New York; pp:
344-351.
[5]
Beers M and Berkow R. The Merck
Manual; 17th Ed. 1999. Multiple
sclerosis; pp: 1474-1476.
[6]
Pizzorno J, Murray M, and Joiner-Bey
H. The Clinician's Handbook of
Natural Medicine. 2002 Churchill
Livingstone, New York; pp:
344-351.
[7]
Beers M and Berkow R. The Merck
Manual; 17th Ed. 1999. Multiple
sclerosis; pp: 1474-1476.
[8]
Pizzorno J, Murray M, and Joiner-Bey
H. The Clinician's Handbook of
Natural Medicine. 2002 Churchill
Livingstone, New York; pp:
344-351.
[9]
Beers M and Berkow R. The Merck
Manual; 17th Ed. 1999. Multiple
sclerosis; pp: 1474-1476.
[10]
www.msfacts.org The Multiple
Sclerosis Foundation. November
2004.
[11]
Beers M and Berkow R. The Merck
Manual; 17th Ed. 1999. Multiple
sclerosis; pp: 1474-1476.
[12]
Tomassini V et al. Comparison of
the effects of acetyl-l-carnitine
and amantadine for the treatment
of fatigue in multiple sclerosis:
results of a pilot, randomized,
double blind, crossover trial. J
Neurol Sci. 2004 Mar 15;
218(1-2): 103-108.
[13]
Nordvik I, Myhr KM, Nyland H,
Bjerve KS. Effect of dietary
advice and n-3 supplementation in
newly diagnosed multiple sclerosis
patients. Acta Neurol Scand.
2000 Sep; 102(3): 193-200.
[14]
Dworkin RH, Bates D, Millar JH,
Paty DW. Linoleic acid and
multiple sclerosis: a reanalysis
of three double blind trials.
Neurology. 1984 Nov; 34(11):
1441-1445.
[15]
Sandyk R, Awerbuch GI. Vitamin
B12 and its relationship to age of
onset in multiple sclerosis. Int
J Neurosci. 1993 Jul-Aug;
71(1-4): 93-99.
[16]
Kira J, Tobimatsu S, Goto I.
Vitamin B12 metabolism and massive
dose methyl Vitamin B12 therapy in
Japanese patients with multiple
sclerosis. Intern Med. 1994 Feb;
33(2): 82-86.
[17]
Gilgun-Sherki Y, Melamed E, Offen
D. The role of oxidative stress
in the pathogenesis of multiple
sclerosis: the need for effective
antioxidant therapy. J Neurol.
2004 Mar; 251(3): 261-268.
[18]
Mai J, Sorenson PS, Hansen JC.
High dose antioxidant
supplementation to multiple
sclerosis patients. Effect on
glutathione peroxidase, clinical
safety, and absorption of
selenium.
[19]
Butterfield DA et al. Vitamin E
and neurodegenerative disorders
associated with oxidative stress.
Nutr Neurosci. 2002 Sep; 5(4):
229-239.
|